Advertisement
Screener

ASSERTIO THERAPEUTICS, INC. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights

ASSERTIO THERAPEUTICS, INC. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2020-04-02: Reporting owner Bukofzer Stan; Form 4/A; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2020-04-02: Reporting owner Bukofzer Stan; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2020-03-30: Reporting owner Galeota James JR; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2020-02-18: Reporting owner Mason Heather L; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2020-04-02Bukofzer Stan
Officer (SVP, Chf Scitfc & Tech Officer)
4/ARestricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−25,370
40,584 owned after
$0.002020-04-03
2020-04-02Bukofzer Stan
Officer (SVP, Chf Scitfc & Tech Officer)
4Restricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−25,370
40,584 owned after
$0.002020-04-03
2020-03-30Galeota James JR
Director
4Restricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−12,492
24,983 owned after
$0.002020-03-31
2020-02-18Mason Heather L
Director
4Restricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−14,394
28,788 owned after
$0.002020-02-19
2020-02-12Peisert Daniel A.
Officer (SVP and CFO)
4Restricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−27,588
55,175 owned after
$0.002020-02-12
2020-02-12HIGGINS ARTHUR J
Director, Officer (Director, President and CEO)
4Restricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−97,412
194,825 owned after
$0.002020-02-12
2020-02-12Bukofzer Stan
Officer (SVP, Chf Scitfc & Tech Officer)
4Restricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−27,588
55,175 owned after
$0.002020-02-12
2020-02-06Peisert Daniel A.
Officer (SVP and CFO)
4Restricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−6,700
6,700 owned after
$0.002020-02-06
2020-02-06HIGGINS ARTHUR J
Director, Officer (Director, President and CEO)
4Restricted Stock Units
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−62,399
62,401 owned after
$0.002020-02-06
2020-02-04Peisert Daniel A.
Officer (SVP and CFO)
4Restricted Stock Units
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+371,622
371,622 owned after
$0.002020-02-06
2020-02-04HIGGINS ARTHUR J
Director, Officer (Director, President and CEO)
4Restricted Stock Units
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,037,838
1,037,838 owned after
$0.002020-02-06
2020-02-04Bukofzer Stan
Officer (SVP, Chf Scitfc & Tech Officer)
4Restricted Stock Units
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+326,577
326,577 owned after
$0.002020-02-06